APO LET 2.5 (Letrozole 2.5 mg)
Pill with imprint APO LET 2.5 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Apotex Corp..
Letrozole is used in the treatment of female infertility; breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO LET 2.5
Letrozole
- Imprint:
- APO LET 2.5
- Strength:
- 2.5 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Aromatase inhibitors
Hormones/antineoplastics - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Apotex Corp.
- Inactive Ingredients:
- hydroxypropyl cellulose
hypromelloses
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol 8000
sodium starch glycolate type A potato
titanium dioxide
ferric oxide yellow
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 68084-0803 | Amerisource Health Services |
More about letrozole
- Letrozole Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 126 Reviews
- Drug class: aromatase inhibitors
Consumer resources
Other brands: Femara
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
